8-O-sulfo-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)

Term ID

CHEBI:194084

Synonyms

8-O-sulfo-ganglioside GM1b(2-)
an 8-O-sulfo-ganglioside GM1b

Definition

An organosulfate oxoanion obtained by deprotonation of the sulfate and neuraminosyl carboxy groups of 8-O-sulfo-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide; major species at pH 7.3.

References

PMID:35864127

Ontology

ChEBI ( EBI )

Relationships

is a type of: organosulfate oxoanion

organosulfate oxoanion Show first 5 Terms

Phenotype

Phenotype resulting from 8-O-sulfo-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)

Phenotype where environments contain 8-O-sulfo-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)

Phenotype modified by environments containing 8-O-sulfo-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)

Human Disease Model